These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6704099)

  • 1. Inhibition of complement-induced [14C]sucrose release by intracellular and extracellular monoclonal antibodies to C9: evidence that C9 is a transmembrane protein.
    Morgan BP; Luzio JP; Campbell AK
    Biochem Biophys Res Commun; 1984 Jan; 118(2):616-22. PubMed ID: 6704099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement pores in erythrocyte membranes. Analysis of C8/C9 binding required for functional membrane damage.
    Sims PJ
    Biochim Biophys Acta; 1983 Aug; 732(3):541-52. PubMed ID: 6871214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement channels in membranes: inhibition with a monoclonal antibody to a neoantigen of polymerized C9.
    Dalmasso AP; Benson BA; Falk RJ
    Biochem Biophys Res Commun; 1984 Dec; 125(3):1013-9. PubMed ID: 6517929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the formation of the complement membrane-attack complex by a monoclonal antibody to the complement component C8 alpha subunit.
    Abraha A; Luzio JP
    Biochem J; 1989 Dec; 264(3):933-6. PubMed ID: 2695070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of C8 and C9 in the C5b-9 complex across the erythrocyte membrane into the cytoplasmic space.
    Whitlow MB; Ramm LE; Mayer MM
    J Biol Chem; 1985 Jan; 260(2):998-1005. PubMed ID: 2857173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steady-state analysis of tracer exchange across the C5b-9 complement lesion in a biological membrane.
    Sims PJ; Lauf PK
    Proc Natl Acad Sci U S A; 1978 Nov; 75(11):5669-73. PubMed ID: 281715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement C9 is inserted into membranes in a globular conformation.
    Marazziti D; Luzio JP; Stanley KK
    FEBS Lett; 1989 Jan; 243(2):347-50. PubMed ID: 2917655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restriction of cell lysis by homologous complement: I. An analysis of membrane attack complex formation on target membranes.
    Houle JJ; Hoffmann EM; Esser AF
    Blood; 1988 Feb; 71(2):280-6. PubMed ID: 3337896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between channel size and the number of C9 molecules in the C5b-9 complex.
    Ramm LE; Whitlow MB; Mayer MM
    J Immunol; 1985 Apr; 134(4):2594-9. PubMed ID: 2579147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunolocalization of complement component C9 on necrotic and non-necrotic muscle fibres in myositis using monoclonal antibodies: a primary role of complement in autoimmune cell damage.
    Morgan BP; Sewry CA; Siddle K; Luzio JP; Campbell AK
    Immunology; 1984 May; 52(1):181-8. PubMed ID: 6370840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.
    Falk RJ; Dalmasso AP; Kim Y; Tsai CH; Scheinman JI; Gewurz H; Michael AF
    J Clin Invest; 1983 Aug; 72(2):560-73. PubMed ID: 6348093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species-restricted target cell lysis by human complement: complement-lysed erythrocytes from heterologous and homologous species differ in their ratio of bound to inserted C9.
    Hu VW; Shin ML
    J Immunol; 1984 Oct; 133(4):2133-7. PubMed ID: 6470486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct measurement of the increase in intracellular free calcium ion concentration in response to the action of complement.
    Campbell AK; Daw RA; Hallett MB; Luzio JP
    Biochem J; 1981 Feb; 194(2):551-60. PubMed ID: 6272733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the mechanism of cell membrane damage by complement: evidence on insertion of polypeptide chains from C8 and C9 into the lipid bilayer of erythrocytes.
    Hammer CH; Shin ML; Abramovitz AS; Mayer MM
    J Immunol; 1977 Jul; 119(1):1-8. PubMed ID: 559700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore.
    Bhakdi S; Tranum-Jensen J
    J Immunol; 1986 Apr; 136(8):2999-3005. PubMed ID: 3958488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmembrane channel formation by complement: functional analysis of the number of C5b6, C7, C8, and C9 molecules required for a single channel.
    Ramm LE; Whitlow MB; Mayer MM
    Proc Natl Acad Sci U S A; 1982 Aug; 79(15):4751-5. PubMed ID: 6289316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of the complement C9 binding domain in paramyosin of the blood fluke Schistosoma mansoni.
    Deng J; Gold D; LoVerde PT; Fishelson Z
    Int J Parasitol; 2007 Jan; 37(1):67-75. PubMed ID: 17123534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the cause and nature of C9-related heterogeneity of terminal complement complexes generated on target erythrocytes through the action of whole serum.
    Bhakdi S; Tranum-Jensen J
    J Immunol; 1984 Sep; 133(3):1453-63. PubMed ID: 6747293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels.
    Zalman LS; Wood LM; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6975-9. PubMed ID: 2428045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies demonstrate protection of polymorphonuclear leukocytes against complement attack.
    Campbell AK; Morgan BP
    Nature; 1985 Sep 12-18; 317(6033):164-6. PubMed ID: 4033797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.